Company
Powder Pharmaceuticals, Inc. (PPI) is a pharmaceutical company based in Hong Kong which focuses on developing and manufacturing non-invasive and innovative pharmaceutical products. PPI is associates company of Lee's Pharmaceutical. The first approved product of PPI is Zingo™. PPI commercial manufacturing facility is approved by the U.S. FDA and located in Hong Kong Science Park. Zingo™ (lidocaine hydrochloride monohydrate) powder intradermal injection system, is an easy-to-administer, single-use, needle-free system that reduces the pain associated with peripheral intravenous (IV) line placements and blood draws in children three to 18 years of age and with blood draws for adults.
